Home Cart 0 Sign in  
X

[ CAS No. 89464-87-9 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 89464-87-9
Chemical Structure| 89464-87-9
Chemical Structure| 89464-87-9
Structure of 89464-87-9 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 89464-87-9 ]

Related Doc. of [ 89464-87-9 ]

Alternatived Products of [ 89464-87-9 ]

Product Details of [ 89464-87-9 ]

CAS No. :89464-87-9 MDL No. :MFCD09750038
Formula : C6H9N3O Boiling Point : -
Linear Structure Formula :- InChI Key :NIQNPTQRAGJGPS-UHFFFAOYSA-N
M.W : 139.16 Pubchem ID :10701894
Synonyms :

Calculated chemistry of [ 89464-87-9 ]

Physicochemical Properties

Num. heavy atoms : 10
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.33
Num. rotatable bonds : 1
Num. H-bond acceptors : 3.0
Num. H-bond donors : 1.0
Molar Refractivity : 37.89
TPSA : 61.03 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -7.05 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.44
Log Po/w (XLOGP3) : 0.14
Log Po/w (WLOGP) : 0.38
Log Po/w (MLOGP) : -0.52
Log Po/w (SILICOS-IT) : 0.59
Consensus Log Po/w : 0.41

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.17
Solubility : 9.43 mg/ml ; 0.0678 mol/l
Class : Very soluble
Log S (Ali) : -0.98
Solubility : 14.6 mg/ml ; 0.105 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -1.78
Solubility : 2.31 mg/ml ; 0.0166 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.36

Safety of [ 89464-87-9 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 89464-87-9 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 89464-87-9 ]
  • Downstream synthetic route of [ 89464-87-9 ]

[ 89464-87-9 ] Synthesis Path-Upstream   1~5

  • 1
  • [ 74290-65-6 ]
  • [ 89464-87-9 ]
YieldReaction ConditionsOperation in experiment
75% With sodium methylate; sodium In methanol; water (i)
2-Amino-3-bromo-5-methylpyrazine (0.374 g) was added to a freshly prepared solution of sodium methoxide in methanol (made by addition of sodium (0.115 g) to methanol (6 ml)).
The reaction was heated under reflux for 18 hours, cooled to ambient temperature and the solvent removed by evaporation.
Water (5 ml) was added to the residue and extracted with dichloromethane (3*20 ml).
The combined organic extracts were dried (MgSO4) and the solvent removed by evaporation.
The residue was purified by chromatography on silica gel, eluding with dichloromethane to give 2-amino-3-methoxy-5-methylpyrazine as a white crystalline solid (0.208 g, 75percent), m.p. 67°-69° C.; mass spectrum (+ve CI): 140 (M+H)+.
75% With sodium methylate; sodium In methanol; water (b)
2-Amino-3-bromo-5-methylpyrazine (0.374 g) was added to a freshly prepared solution of sodium methoxide in methanol (made by addition of sodium (0.115 g) to methanol (6 ml)).
The reaction was heated under reflux for 18 hours, cooled to ambient temperature and the solvent removed by evaporation.
Water (5 ml) was added to the residue and extracted with dichloromethane (3*20 ml).
The combined organic extracts were dried (MgSO4) and the solvent removed by evaporation.
The residue was purified by chromatography on silica gel, eluding with dichloromethane to give 2-amino-3-methoxy-5-methylpyrazine as a white crystalline solid (0.208 g, 75percent), m.p. 67°-69° C.; mass spectrum (+ve CI): 140 (M+H)+.
75% With sodium methylate; sodium In methanol; water (ii)
2-Amino-3-bromo-5-methylpyrazine (0.374 g) was added to a freshly prepared solution of sodium methoxide in methanol (made by addition of sodium (0.115 g) to methanol (6 ml).
The reaction mixture was heated under reflux for 18 hours, cooled to ambient temperature and the solvent removed by evaporation.
Water (5 ml) was added to the residue and extracted with dichloromethane (3*20 ml).
The combined organic extracts were dried (MgSO4) and the solvent removed by evaporation.
The residue was purified by chromatography on silica gel, eluding with dichloromethane to give 2-amino-3-methoxy-5-methylpyrazine as a white crystalline solid (0.208 g, 75percent), m.p. 67°-69° C.; mass spectrum (+ve CI): 140 (M+H)+.
Reference: [1] Patent: US5861401, 1999, A,
[2] Patent: US5866568, 1999, A,
[3] Patent: US5668137, 1997, A,
  • 2
  • [ 67-56-1 ]
  • [ 124-41-4 ]
  • [ 74290-65-6 ]
  • [ 89464-87-9 ]
YieldReaction ConditionsOperation in experiment
92% at 30 - 100℃; for 6 h; Inert atmosphere [00791] To a mixture of 3-bromo-5-methyl-pyrazin-2-amine (31 g, 164.87 mmol) in MeOH (150 mL) was added NaOMe (14 g, 263.79 mmol) in one portion at 30 °C under N2. The mixture was stirred at 100 °C for 6 hrs. The mixture was concentrated under reduced pressure and the resulting residue was dissolved in water (100 mL). The mixture was extracted with EtOAc and the combined organic layers were washed with brine (20 mL), dried with Na2S04, filtered and concentrated under reduced pressure. The resulting residue was purified by column chromatography (to afford 3-methoxy-5-methyl-pyrazin-2-amine (21 g, 92percent yield) as a white solid. 1H MR (400 MHz, CDCh-d) δ ppm 7.39 (s, 1H) 4.59 (br s, 2 H) 3.97 (s, 3 H) 2.29 (s, 3 H)
Reference: [1] Patent: WO2018/136265, 2018, A1, . Location in patent: Paragraph 00791
  • 3
  • [ 202409-04-9 ]
  • [ 89464-87-9 ]
Reference: [1] Patent: US5877319, 1999, A,
  • 4
  • [ 124-41-4 ]
  • [ 74290-65-6 ]
  • [ 89464-87-9 ]
Reference: [1] Journal of Medicinal Chemistry, 1997, vol. 40, # 6, p. 996 - 1004
  • 5
  • [ 5521-58-4 ]
  • [ 89464-87-9 ]
Reference: [1] Patent: WO2018/136265, 2018, A1,
Same Skeleton Products
Historical Records

Pharmaceutical Intermediates of
[ 89464-87-9 ]

Zibotentan Intermediates

Chemical Structure| 6298-19-7

[ 6298-19-7 ]

2-Chloropyridin-3-amine

Related Functional Groups of
[ 89464-87-9 ]

Ethers

Chemical Structure| 4774-10-1

[ 4774-10-1 ]

3-Methoxypyrazin-2-amine

Similarity: 0.83

Chemical Structure| 89464-86-8

[ 89464-86-8 ]

2-Amino-3-ethoxypyrazine

Similarity: 0.80

Chemical Structure| 2882-21-5

[ 2882-21-5 ]

2-Methoxy-6-methylpyrazine

Similarity: 0.80

Chemical Structure| 53163-97-6

[ 53163-97-6 ]

2-Ethoxy-6-methylpyrazine

Similarity: 0.77

Chemical Structure| 210993-11-6

[ 210993-11-6 ]

2-Hydrazinyl-3-methoxypyrazine

Similarity: 0.73

Amines

Chemical Structure| 4774-10-1

[ 4774-10-1 ]

3-Methoxypyrazin-2-amine

Similarity: 0.83

Chemical Structure| 89464-86-8

[ 89464-86-8 ]

2-Amino-3-ethoxypyrazine

Similarity: 0.80

Chemical Structure| 210993-11-6

[ 210993-11-6 ]

2-Hydrazinyl-3-methoxypyrazine

Similarity: 0.73

Chemical Structure| 5900-13-0

[ 5900-13-0 ]

5-Bromo-3-methoxypyrazin-2-amine

Similarity: 0.69

Chemical Structure| 874-31-7

[ 874-31-7 ]

2-Amino-5-chloro-3-methoxypyrazine

Similarity: 0.69

Related Parent Nucleus of
[ 89464-87-9 ]

Pyrazines

Chemical Structure| 4774-10-1

[ 4774-10-1 ]

3-Methoxypyrazin-2-amine

Similarity: 0.83

Chemical Structure| 89464-86-8

[ 89464-86-8 ]

2-Amino-3-ethoxypyrazine

Similarity: 0.80

Chemical Structure| 2882-21-5

[ 2882-21-5 ]

2-Methoxy-6-methylpyrazine

Similarity: 0.80

Chemical Structure| 53163-97-6

[ 53163-97-6 ]

2-Ethoxy-6-methylpyrazine

Similarity: 0.77

Chemical Structure| 210993-11-6

[ 210993-11-6 ]

2-Hydrazinyl-3-methoxypyrazine

Similarity: 0.73